PGY1 Pharmacy ResidentUniversity of North Carolina HospitalsChapel Hill, North Carolina, United States
OC 26.4 - Questioning the benefit of Caplacizumab for the treatment of acquired Thrombotic Thrombocytopenic Purpura: a real-world, single center experience
Sunday, June 23, 202415:30 – 15:45 ICT